ImmuONE
PrivateLast Round
VC Round
Mar 13, 2025
Total Funding Raised
$2.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ImmuONE is a biotechnology company that provides innovative respiratory in vitro cell culture products and contract research services for inhalation safety testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Compliance
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmuONE Comparables
Compare ImmuONE with similar companies based on industry and business-model similarity.
ImmuONE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 13, 2025 | ||||
| Seed | Oct 26, 2023 |
Key People
Founding team and executive leadership
ImmuONE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Group | Seed, VC Round |
| British Business Bank | Seed, VC Round |
| Mercia Ventures | VC Round, Seed |
| Mercia Ventures | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors increased 174% MoM, reaching 2K.
- Apr 16, 2026
Monthly visitors increased 43% MoM.
ImmuONE Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImmuONE's valuation, stock price, and market status.